SPONSOR
Biocity Biopharmaceutics Co., Ltd.
Total Trials
2
Recruiting
2
Phases
Phase 3, Phase 1
NCT06819826 Phase 3
Recruiting
A Study of SC0062 Capsule for the Treatment of IgA Nephropathy with Proteinuria
IgA Nephropathy (IgAN)
NCT07368478 Phase 1
Recruiting
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Preliminary Efficacy of BC2027 in Patients With Advanced Solid Malignancies
Advanced Solid Malignancies